Methods and devices for in situ formed nerve cap with rapid release
Abstract
Disclosed are methods, devices and materials for the in situ formation of an implant for treating a nerve. A treatment site on a nerve is positioned within a cavity defined by a form. A transformable media is introduced into the form cavity to surround the treatment site. The media is permitted to undergo a transformation from a first, relatively flowable state to a second, relatively non flowable state to form a protective barrier surrounding the treatment site. A hydrophilic characteristic of the media cooperates with a hydrophobic characteristic of the surface of the cavity to facilitate a rapid release of the implant from the cavity following the transformation. The implant may be a growth inhibiting nerve cap to inhibit neuroma formation following planned or traumatic nerve injury, a growth permissive conduit for facilitating reconnection of a severed nerve, or an anchor for stabilizing a pain management electrode with respect to a nerve. Access to the nerve treatment site may be open surgical or percutaneous.
Claims
exact text as granted — not AI-modified1 . A method of in situ formation of an implant, comprising the steps of:
identifying a nerve; positioning the nerve in a cavity defined by a form; introducing media into the cavity to surround the nerve; and permitting the media to undergo a transformation from a first, relatively flowable state to a second, relatively non flowable state to form a protective barrier surrounding the nerve; wherein a hydrophilic characteristic of the media cooperates with a hydrophobic characteristic of the cavity to facilitate a rapid release of the implant from the cavity following the transformation.
2 . The method of in situ formation as in claim 1 , comprising positioning a severed end of a nerve into the cavity, and permitting the media to undergo a transformation state to form a protective barrier surrounding the severed end of the nerve.
3 . The method of in situ formation as in claim 1 , wherein the implant can be removed from the cavity by a pull force of no more than about 10 N, applied for no more than about 5 seconds.
4 . The method of in situ formation as in claim 1 , wherein the implant can be removed from the cavity by a pull force of no more than about 5 N.
5 . The method of in situ formation as in claim 1 , wherein the implant can be removed from the cavity by a pull force of no more than about 2 N applied for no more than about 2 seconds.
6 . The method of in situ formation as in claim 1 , wherein the implant can be removed from the cavity within about 2 seconds, without disrupting attachment between the implant and the nerve.
7 . The method of in situ formation as in claim 1 , wherein the in situ formation occurs through chemical or photo crosslinking.
8 . The method of in situ formation as in claim 1 , wherein the introducing media step includes introducing a first volume of media, and following transformation of the first volume, introducing a second volume of media.
9 . A method of in situ formation of an implant, comprising the steps of:
identifying an implant formation site; positioning a form having an implant cavity at the site; introducing media into the cavity to form an implant precursor; and permitting the media to undergo a transformation from a first, relatively flowable state to a second, relatively non flowable state to form the implant; wherein a hydrophilic characteristic of the media cooperates with a hydrophobic characteristic of the cavity to facilitate a rapid release of the implant from the cavity following the transformation.
10 . The method of in situ formation as in claim 9 , wherein the implant is a nerve cap for inhibiting neuroma formation around a severed nerve end.
11 . The method of in situ formation as in claim 9 , wherein the implant is a nerve conduit for guiding growth of a nerve.
12 . The method of in situ formation as in claim 9 , wherein the implant is a nerve wrap for preventing scar tissue-related nerve compression and nerve tethering.
13 . The method of in situ formation as in claim 9 , wherein the implant reduces the incidence or persistence of chronic pain.
14 . The method of in situ formation as in claim 9 , wherein the implant is a tissue bulking implant.
15 . The method of in situ formation as in claim 9 , wherein the implant is a vascular occlusion device.
16 . The method of in situ formation as in claim 9 , wherein the implant is a tendon repair device.
17 . A method of in situ formation of a nerve cap, comprising the steps of:
identifying a severed end of a nerve; positioning the severed end into a cavity defined by a form; introducing media into the cavity to surround the severed end; and permitting the media to undergo a transformation from a first, relatively flowable state to a second, relatively non flowable state to form a protective barrier surrounding the severed nerve end; wherein a hydrophilic characteristic of the media cooperates with a hydrophobic characteristic of the cavity to facilitate a rapid release of the nerve cap from the cavity following the transformation.
18 . A method of in situ formation of a nerve cap as in claim 17 , further comprising the step of removing the form.
19 . A method of in situ formation of a nerve cap as in claim 17 , comprising identifying a surgically or traumatically severed nerve.
20 . A method of in situ formation of a nerve cap as in claim 17 , wherein the form comprises a nerve guide, and said positioning step comprises positioning the nerve such that the nerve guide maintains the severed end within the cavity spaced apart from a sidewall of the form.
21 .- 99 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.